| Status: AWMSG assessment in progress | |
For the off-label treatment of immune checkpoint inhibitor (ICI) induced grade 3-4 pneumonitis, where symptoms have not responded to first line immunosuppression with corticosteroids. |
|
Medicine details |
|
| Medicine name | infliximab |
| Formulation | Powder for concentrate for solutionfor infusion |
| Reference number | OW34 |
| Indication | As above |
| Company | various |
| BNF chapter | Malignant disease & immunosuppression |
| Assessment type | One Wales |
| Status | AWMSG assessment in progress |
| Scrutiny Panel meeting date | 11/09/2025 |
| OWMAG meeting date | 08/12/2025 |
| AWMSG meeting date | 11/02/2026 |